GlucoSet
PrivateLast Round
Series A
Jul 7, 2023
Total Funding Raised
$5.78M
Company Overview
GlucoSet operates in Healthcare & Life Sciences and is based in Trondheim. Its latest recorded funding round was a Grant round in January 2023.
GlucoSet is a medical technology company developing a novel continuous glucose monitor for critical care patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlucoSet Comparables
Compare GlucoSet with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flowsion A/S | 87% | |
| Admetsys Corporation | 81% | |
| Getinge AB | 81% |
For institutional investors. Book with your work email.
GlucoSet Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 7, 2023 | ||||
| Grant | Jan 1, 2023 | ||||
| Grant | Dec 19, 2022 | ||||
| Grant | Nov 5, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GlucoSet Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, Series A |
| Norsk Innovasjonskapital IV | Series A, Seed |
| MP Pensjon | Seed |
| Credit Suisse Group AG | Series A |
| Diabetes Center Berne | Grant |
| European Innovation Council Fund | Grant |
| The Research Council of Norway | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 5, 2021
$100K raised from Diabetes Center Berne
For institutional investors. Book with your work email.
GlucoSet Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GlucoSet's valuation, stock price, and market status.
Is GlucoSet a public or private company?
GlucoSet is a private company.
What is the current stock price of GlucoSet?
GlucoSet is a private company, so its shares have no public market price. Caplight tracks GlucoSet's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GlucoSet worth (valuation)?
Valuation information for GlucoSet is not publicly available.
Can I buy GlucoSet stock?
GlucoSet shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GlucoSet's last funding round?
GlucoSet's most recent funding round was Series A on July 7, 2023.
Who are the main investors in GlucoSet?
Key investors in GlucoSet include Norsk Innovasjonskapital IV, Credit Suisse Group AG.
Will GlucoSet IPO soon?
No public IPO plans have been announced for GlucoSet.
How can I track GlucoSet secondary market activity?
Caplight tracks bids, offers, and trades in GlucoSet's shares on secondary markets.